Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities
Keywords: RAS; rennin-angiotensin system; AII; angiotensin II; ARBs; angiotensin II receptor blockers; FDA; US Food and Drug Administration; DMAP; 4-(dimethylamino)pyridine; NMR; nuclear magnetic resonance; HRMS; high-resolution mass spectrometry; ESI; electrospr